Drug Trial Radar · NCT07229742
A Phase II Clinical Study on the Efficacy and Safety of SHR-2173 Injection in the Treatment of Patients With Active Lupus Nephritis
Last checked: Nov 19, 2026Latest source record: Dec 1, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
51
Planned (sponsor's estimate)
Start
Nov 22, 2025
Primary completion
Jun 2027
Study completion Mar 2028
Sponsor
- Lead sponsor
- Guangdong Hengrui Pharmaceutical Co., LtdIndustry
- Sponsor type
- Industry
- First posted
- Nov 17, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study is a Phase II clinical trial to evaluate the efficacy and safety of SHR-2173 in patients with lupus nephritis (LN). It adopts a randomized, double-blind, placebo-controlled, multicenter trial design.
Conditions
- Active Lupus Nephritis
Interventions
SHR-2173 InjectionDrug
SHR-2173 injection.
SHR-2173 Injection Blank PreparationDrug
SHR-2173 injection blank preparation.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The ratio of 24-hour urine protein-creatinine ratio (24-hour UPCR) to the baseline.Time frame: At Week 24.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The General Hospital of the Eastern Theater Command of the People's Liberation Army of China
Nanjing, Jiangsu, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.